World Journal of Urology

• 

  Publication Venue For

  • Incidence, risk factors, and outcome of Clostridioides difficile infection following urological surgeries..  39:2995-3003. 2021
  • The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy..  38:3113-3119. 2020
  • Next-day discharge after minimally invasive partial nephrectomy: an analysis of the US National Surgical Quality Improvement Program..  37:831-836. 2019
  • Determining optimal prostate-specific antigen thresholds to identify an increased 4-year risk of prostate cancer development: an analysis within the Veterans Affairs Health Care System..  34:1107-1113. 2016
  • Nephrostomy in percutaneous nephrolithotomy (PCNL): does nephrostomy tube size matter? Results from The Global PCNL Study from The Clinical Research Office Endourology Society.  1-6. 2012
  • Holmium laser for stone management..  25:235-239. 2007
  • Fascicular anatomy and surgical access of the human pudendal nerve..  23:411-418. 2005
  • Contemporary chemotherapeutic approaches for the treatment of hormone-refractory prostate carcinoma..  18:216-221. 2000
  • Outcome profiles of locoregional disease after radical prostatectomy and radiotherapy..  18:173-178. 2000
  • Gene therapy in urologic oncology..  18:91-92. 2000
  • Dorsal onlay urethroplasty for urethral stricture repair..  16:181-185. 1998
  • Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro..  16:405-409. 1998
  • Molecular determinants of sexual differentiation..  14:278-294. 1996
  • Does radical prostatectomy in the presence of positive pelvic lymph nodes enhance survival?.  12:308-312. 1994
  • The impact of the "cisplatin era" of treatment on survival in testicular cancer.  9:45-50. 1991
  • Augmentation cystoplasty.  8:203-207. 1990
  • Refusal of cancer therapy in testicular cancer: Recognizing and preventing a significant problem.  8:58-62. 1990
  • The evolving role for surgery in the management of nonseminomatous testicular carcinoma.  8:13-19. 1990
  • Editorial.  7:1. 1989
  • Stage A prostatic adenocarcinoma - An artifact of detection.  7:34-37. 1989
  • The role of radical prostatectomy in the management of prostatic adenocarcinoma - Biologic factors influencing the likelihood of local and systemic control.  7:38-44. 1989
  • Repair of the difficult posterior urethral stricture.  5:30-36. 1987
  • A review: prostate monoclonal antibodies - the magic bullet.  4:193-199. 1986
  • Management of locally advanced prostatic carcinoma by surgery: does screening for prostatic cancer make sense?.  4:129-135. 1986
  • Treatment of superficial carcinoma of the bladder.  4:52-59. 1986
  • A new technique for the prevention of reflux in those undergoing bladder substitution or undiversion using bowel segments.  3:194-196. 1985
  • Laboratory chemosensitivity testing of human bladder carcinoma.  3:104-109. 1985
  • Prognostic factors predicting treatment response.  2:99-102. 1984
  • Testicular seminoma revisited: Time for a multimodal therapeutic approach.  2:68-72. 1984
  • Editorial comment.  1:2. 1983
  • Radical surgery for the management of prostatic carcinoma.  1:29-35. 1983